A retrospective study on the efficacy of Roxadustat in peritoneal dialysis patients with erythropoietin hyporesponsiveness

CONCLUSIONS: For PD patients with erythropoietin hyporesponsiveness, roxadustat can significantly improve renal anemia. The efficacy of roxadustat in improving renal anemia was not affected by baseline levels of hs-CRP0 and iPTH.PMID:38649158 | DOI:10.3904/kjim.2023.520

Source: The Korean Journal of Internal Medicine - April 22, 2024 Category: Internal Medicine Authors: Jie Liu Shuang Li Fan Yang Tianyu Li Rui Li Yousuf Waheed Chen Meng Shulin Li Kun Liu Yanshan Tong Haisheng Xu Chuankuo Tian Xinglei Zhou Source Type: research